Syros Pharmaceuticals
Utility Patents

Last updated:

List of all Syros Pharmaceuticals patents 12 in total

Status Patent
Grant
Utility: Inhibitors of cyclin dependent kinase 7 (CDK7) External link
Filling date: 6 Sep 2025 Issue date: 26 Apr 2022
Grant
Utility: Compounds for the modulation of MYC activity External link
Filling date: 6 Sep 2025 Issue date: 15 Mar 2022
Grant
Utility: Compounds for the modulation of Myc activity External link
Filling date: 6 Sep 2025 Issue date: 21 Sep 2021
Grant
Utility: Compositions of cyclin dependent kinase 7 (CDK7) inhibitor External link
Filling date: 6 Sep 2025 Issue date: 10 Aug 2021
Grant
Utility: Methods of stratifying patients for treatment with retinoic acid receptor-.alpha. agonists External link
Filling date: 6 Sep 2025 Issue date: 6 Jul 2021
Grant
Utility: Heteroaromatic compounds useful for the treatment of proliferative diseases External link
Filling date: 6 Sep 2025 Issue date: 22 Jun 2021
Grant
Utility: Pyrrolotriazine compounds and methods of inhibiting TAM kinases External link
Filling date: 6 Sep 2025 Issue date: 22 Jun 2021
Grant
Utility: Inhibitors of cyclin-dependent kinase 7 (CDK7) External link
Filling date: 6 Sep 2025 Issue date: 15 Dec 2020
Grant
Utility: Compounds for the modulation of myc activity External link
Filling date: 6 Sep 2025 Issue date: 29 Sep 2020
Grant
Utility: Inhibitors of cyclin-dependent kinase 7 (CDK7) External link
Filling date: 6 Sep 2025 Issue date: 11 Aug 2020
Grant
Utility: Methods of stratifying patients for treatment with retinoic acid receptor-alpha agonists External link
Filling date: 6 Sep 2025 Issue date: 30 Jun 2020
Grant
Utility: Inhibitors of cyclin-dependent kinase 7 (CDK7) External link
Filling date: 6 Sep 2025 Issue date: 31 Dec 2019

Showing 1 to 12 of 12 patents.